Roswell Park-Led Clinical Trial Paves Way for FDA Approval of Targeted Drug for Aggressive Leukemia
December 02, 2025
December 02, 2025
BUFFALO, New York, Dec. 2 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:
* * *
Roswell Park-Led Clinical Trial Paves Way for FDA Approval of Targeted Drug for Aggressive Leukemia
*
BUFFALO, N.Y. The U.S. Food and Drug Administration has approved a new drug to treat an aggressive form of leukemia, based on the results of a clinical trial co-led by Eunice Wang, MD, Chief of Leukemia at R . . .
* * *
Roswell Park-Led Clinical Trial Paves Way for FDA Approval of Targeted Drug for Aggressive Leukemia
*
BUFFALO, N.Y. The U.S. Food and Drug Administration has approved a new drug to treat an aggressive form of leukemia, based on the results of a clinical trial co-led by Eunice Wang, MD, Chief of Leukemia at R . . .